3D Global Biotech Inc. (TPEX:6808)
Taiwan
· Delayed Price · Currency is TWD 40.00
-2.15 (-5.10%)
Aug 15, 2025, 2:59 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 3.11 billion as of August 15, 2025. Its market cap has increased by 17.24% in one year.
Market Cap
3.11B
Enterprise Value
2.49B
Revenue
265.69M
Ranking
n/a
PE Ratio
30.77
Stock Price
40.00
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has increased from 2.74B to 3.11B, an increase of 13.79%. That is a compound annual growth rate of 2.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 3.11B | -39.32% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | 2.64B | -3.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 208.61B |
| PharmaEssentia | 165.97B |
| Bora Pharmaceuticals Co., LTD. | 94.94B |
| Lotus Pharmaceutical | 53.66B |
| Oneness Biotech | 32.23B |
| Polaris Group | 27.47B |
| Lumosa Therapeutics | 27.18B |
| Center Laboratories | 26.42B |